Strategic investments strengthen resilience and service capabilities for innovative injectable therapies First of ten additional commercial ma...
If approved, Joenja would be available to eligible patients aged 4 years and older with APDS who weigh 13 kg or more Decision follows recent approval ...
Kadans Science Partner is pleased to welcome ACROBiosystems to The HIVE Innovation Center, its laboratory and office building dedicated to the life scien...
Johnson & Johnson, a worldwide leader in multiple myeloma, announced new data from the Phase 3 MajesTEC-3 study showing sustained disease control and...
Altruist Biologics, a world-class contract development and manufacturing organization (CDMO) and wholly owned subsidiary of Innovent Biologics (1801.HK), a...
BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced that Leqembi is now available at a private clinic in Sweden and that the first patie...
Bioiberica, a global life science company, announces its return to CPHI Milan with a renewed mission to provide the high-quality, traceable and scientifi...
Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organization), reported interim results from a clinical st...
Symbiosis Pharmaceutical Services is entering a new phase of growth following a £26 million investment to expand its ...
NorahLux has launched the Red Light Therapy Research Hub, an interactive research tool designed to make studies on photobiomodulation easier to search an...
Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion r...
Ingelheim, Germany - Boehringer Ingelheim announced the launch of PED Essentials, a comprehensive e-learning hub designed to help patient organizations g...
As biologics and novel modalities become increasingly sophisticated, understanding molecular structure under controlled conditions tells only part ...
For emerging biopharma companies, speed, quality and scalability cannot be treated as separate priorities. As products progress t...
© 2026 Biopharma Boardroom. All Rights Reserved.
